1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. PIERIS PHARMACEUTICALS INC

Pieris Pharmaceuticals Inc

XNAS: PIRS

Watchlist

Portfolio

Share


Insider Trading disclosures for Pieris Pharmaceuticals Inc

The latest disclosure was made by James A. Geraghty in Pieris Pharmaceuticals Inc where a trade of 1 Series F Preferred Stock, par value $0.001 per share done at an average price of $1 was reported to US exchanges on Aug. 7, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
James A. Geraghty Director Purchase of securities on an exchange or from another person at price $ 1.00 per share. 07 Aug 2024 1 1 - 1 1 Series F Preferred Stock, par value $0.001 per share
Christopher Kiritsy Director Purchase of securities on an exchange or from another person at price $ 0.85 per share. 25 May 2023 10,000 20,000 (0%) 0% 0.9 8,500 Common Stock
Stephen S. Yoder Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2023 634,021 634,021 - - Stock Option (Right to buy)
Thomas Bures Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2023 249,080 249,080 - - Stock Option (right to buy)
Hitto Kaufmann Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2023 249,080 249,080 - - Stock Option (Right to buy)
Shane Olwill Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2023 249,080 249,080 - - Stock Option (Right to buy)
Ahmed Mousa Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Feb 2023 249,080 249,080 - - Stock Option (Right to buy)
Tim Demuth Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 1.71 per share. 13 May 2022 6,000 6,000 (0%) 0% 1.7 10,260 Common Stock
Stephen S. Yoder Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 625,874 625,874 - - Stock Option (Right to buy)
Thomas Bures Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 215,819 215,819 - - Stock Options (Right to buy)
Hitto Kaufmann SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 215,819 215,819 - - Stock Option (Right to buy)
Shane Olwill Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 215,819 215,819 - - Stock Option (Right to buy)
Tim Demuth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 100,000 100,000 - - Stock Option (Right to buy)
Ahmed Mousa Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Feb 2022 215,819 215,819 - - Stock Option (Right to buy)
Shane Olwill Chief Development Officer Sale of securities on an exchange or to another person at price $ 5.00 per share. 30 Aug 2021 9,200 33,838 (0%) 0% 5 46,000 Common Stock
Shane Olwill Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 30 Aug 2021 38,400 61,600 - - Stock Option (right to buy)
Shane Olwill Chief Development Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.52 per share. 30 Aug 2021 38,400 43,038 (0%) 0% 1.5 58,368 Common Stock
Shane Olwill Chief Development Officer Sale of securities on an exchange or to another person at price $ 5.15 per share. 30 Aug 2021 29,200 4,638 (0%) 0% 5.2 150,380 Common Stock
Tim Demuth Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Aug 2021 360,000 360,000 - - Stock Option (right to buy)
James A. Geraghty Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 45,000 45,000 - - Stock Option (right to buy)
Michael S. Richman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 40,000 40,000 - - Stock Option (right to buy)
Peter A. Kiener Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 40,000 40,000 - - Stock Option (right to buy)
Matthew L. Sherman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 40,000 40,000 - - Stock Option (right to buy)
Christopher Kiritsy Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 40,000 40,000 - - Stock Option (right to buy)
Ann Barbier Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 40,000 40,000 - - Stock Option (right to buy)
Maya R. Said Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2021 40,000 40,000 - - Stock Option (right to buy)
Stephen S. Yoder Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 530,000 530,000 - - Stock Options (Right to buy)
Thomas Bures Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 150,000 150,000 - - Stock Options (Right to buy)
Hitto Kaufmann SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Mar 2021 220,000 220,000 - - Stock Options (Right to buy)
James A. Geraghty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2020 45,000 45,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2020 40,000 40,000 - - Stock Option (right to buy)
Peter A. Kiener None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2020 40,000 40,000 - - Stock Options (Right to buy)
Matthew L. Sherman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2020 40,000 40,000 - - Stock Option (right to buy)
Christopher Kiritsy None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2020 40,000 40,000 - - Stock Option (right to buy)
Ann Barbier None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2020 40,000 40,000 - - Stock Options (Right to buy)
Maya R. Said None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2020 40,000 40,000 - - Stock Option (right to buy)
Stephen S. Yoder Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2020 420,000 420,000 - - Stock Option (Right to Buy)
Thomas Bures Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2020 80,000 80,000 - - Stock Option (Right to Buy)
Hitto Kaufmann SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Feb 2020 45,000 45,000 - - Stock Option (Right to Buy)
James A. Geraghty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2020 22,500 22,500 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2020 20,000 20,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2020 5,431 5,431 - - Stock Option (right to buy)
Peter A. Kiener None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2020 20,000 20,000 - - Stock Option (right to buy)
Matthew L. Sherman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2020 20,000 20,000 - - Stock Option (right to buy)
Jean-Pierre Bizzari None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2020 20,000 20,000 - - Stock Option (right to buy)
Christopher Kiritsy None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2020 20,000 20,000 - - Stock Option (right to buy)
Ann Barbier None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2020 20,000 20,000 - - Stock Option (right to buy)
Maya R. Said None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2020 20,000 20,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2019 5,165 5,165 - - Stock Options (right to buy)
Hitto Kaufmann SVP, Chief Scientific Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Aug 2019 300,000 300,000 - - Stock Option (right to buy)
Maya R. Said None Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Jul 2019 30,000 30,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2019 3,789 3,789 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2019 5,640 5,640 - - Stock Option (right to buy)
Stephen S. Yoder Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2019 380,000 380,000 - - Stock Options (Right to Buy)
Louis Matis Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2019 96,500 96,500 - - Stock Option (Right to Buy)
Allan Reine Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Feb 2019 162,500 162,500 - - Stock Options (Right to Buy)
James A. Geraghty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2019 25,000 25,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2019 6,096 6,096 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2019 20,000 20,000 - - Stock Option (right to buy)
Peter A. Kiener None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2019 20,000 20,000 - - Stock Option (right to buy)
Steven Prelack None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2019 20,000 20,000 - - Stock Option (right to buy)
Matthew L. Sherman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2019 20,000 20,000 - - Stock Option (right to buy)
Jean-Pierre Bizzari None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2019 20,000 20,000 - - Stock Option (right to buy)
Christopher Kiritsy None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2019 20,000 20,000 - - Stock Option (right to buy)
Ann Barbier None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2019 20,000 20,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2018 3,829 3,829 - - Stock Option (right to buy)
Peter A. Kiener None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Oct 2018 30,000 30,000 - - Stock Option (right to buy)
Matthew L. Sherman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Oct 2018 30,000 30,000 - - Stock Option (right to buy)
Christopher Kiritsy None Purchase of securities on an exchange or from another person at price $ 5.10 per share. 14 Sep 2018 5,000 10,000 (0%) 0% 5.1 25,525 Common Stock
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2018 2,837 2,837 - - Stock Option (right to buy)
James A. Geraghty None Purchase of securities on an exchange or from another person at price $ 5.75 per share. 15 May 2018 10,000 20,000 (0%) 0% 5.8 57,500 Common Stock
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2018 2,665 2,665 - - Stock Option (right to buy)
Ann Barbier None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2018 30,000 30,000 - - Stock Option (right to buy)
Stephen S. Yoder Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2018 325,000 325,000 - - Stock Options (Right to buy)
Louis Matis Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2018 100,000 100,000 - - Stock Options (Right to buy)
Allan Reine Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2018 50,000 50,000 - - Stock Options (Right to buy)
Allan Reine Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Feb 2018 53,833 53,833 - - Stock Options (Right to buy)
James A. Geraghty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2018 25,000 25,000 - - Stock Option (right to buy)
Julian Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2018 20,000 20,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2018 20,000 20,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2018 2,243 2,243 - - Stock Option (right to buy)
Steven Prelack None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2018 20,000 20,000 - - Stock Option (right to buy)
Jean-Pierre Bizzari None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2018 20,000 20,000 - - Stock Option (right to buy)
Christopher Kiritsy None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2018 20,000 20,000 - - Stock Option (right to buy)
James A. Geraghty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Dec 2017 40,000 40,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2017 4,006 4,006 - - Stock Option (Rights to buy)
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2017 6,115 6,115 - - Stock Options (Right to buy)
James A. Geraghty None Purchase of securities on an exchange or from another person at price $ 4.82 per share. 17 Aug 2017 10,000 10,000 (0%) 0% 4.8 48,200 Common Stock
Allan Reine See Remarks Purchase of securities on an exchange or from another person at price $ 4.89 per share. 16 Aug 2017 20,000 65,000 (0%) 0% 4.9 97,800 Common Stock
Allan Reine See Remarks Purchase of securities on an exchange or from another person at price $ 4.79 per share. 16 Aug 2017 45,000 45,000 (0%) 0% 4.8 215,550 Common Stock
Allan Reine See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2017 450,000 450,000 - - Common Stock
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2017 3,288 3,288 - - Stock Option (right to buy)
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2017 5,018 5,018 - - Stock Option (right to buy)
James A. Geraghty None Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 May 2017 30,000 30,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2017 7,821 7,821 - - Stock Option (right to buy)
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Apr 2017 10,546 10,546 - - Stock Option (right to buy)
Christopher Kiritsy None Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 21 Apr 2017 5,000 25,000 - - Stock Option (right to buy)
Christopher Kiritsy None Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.59 per share. 21 Apr 2017 5,000 5,000 (0%) 0% 1.6 7,950 Common Stock
Louis Matis See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2017 145,000 145,000 - - Stock option (Right to buy)
Julian Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2017 20,000 20,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2017 20,000 20,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2017 9,687 9,687 - - Stock Option (right to buy)
Steven Prelack None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2017 20,000 20,000 - - Stock Option (right to buy)
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2017 10,313 10,313 - - Stock Option (right to buy)
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2017 20,000 20,000 - - Stock Option (right to buy)
Jean-Pierre Bizzari None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2017 20,000 20,000 - - Stock Option (right to buy)
Christopher Kiritsy None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jan 2017 20,000 20,000 - - Stock Option (right to buy)
Claude Knopf Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Nov 2016 500,000 500,000 - - Common Stock
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2016 9,656 9,656 - - Stock Option (right to buy)
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Oct 2016 10,279 10,279 - - Stock Option (right to buy)
Christopher Kiritsy None Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Sep 2016 30,000 30,000 - - Stock Option (right to buy)
Julian Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2016 30,000 30,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2016 9,144 9,144 - - Stock Option (right to buy)
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jul 2016 9,734 9,734 - - Stock Option (right to buy)
Darlene M. Deptula-Hicks SVP, Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Jun 2016 5,000 5,000 - - Common Stock
Stephen S. Yoder Director, President and CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Jun 2016 6,000 6,000 - - Common Stock
Louis Matis SVP, Chief Development Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Jun 2016 2,085 2,085 - - Common Stock
Louis Matis SVP, Chief Development Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 Jun 2016 7,915 10,000 - - Common Stock
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2016 7,679 7,679 - - Stock Option (right to buy)
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Apr 2016 8,174 8,174 - - Stock Option (right to buy)
Stephen S. Yoder Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Feb 2016 434,350 434,350 - - Stock Option (Right to buy)
Steven Prelack None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2016 20,000 20,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2016 20,000 20,000 - - Stock Option (right to buy)
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2016 20,000 20,000 - - Stock Option (right to buy)
Jean-Pierre Bizzari None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2016 20,000 20,000 - - Stock Option (right to buy)
Stephen S. Yoder Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2016 492,000 492,000 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2016 9,654 9,654 - - Stock Option (right to buy)
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jan 2016 10,277 10,277 - - Stock Option (right to buy)
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Oct 2015 8,267 8,267 - - Stock Option (right to buy)
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Oct 2015 8,800 8,800 - - Stock Option (right to buy)
Darlene M. Deptula-Hicks Sr. Vice President and CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Sep 2015 450,000 450,000 - - Common Stock
Louis Matis SVP, Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Aug 2015 500,000 500,000 - - Common Stock
Michael S. Richman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2015 6,310 6,310 - - Stock Option (right to buy)
Chau Q. Khuong Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2015 6,717 6,717 - - Stock Option (right to buy)
Chau Q. Khuong Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jul 2015 495,283 7,194,222 - - Common Stock
Chau Q. Khuong Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jul 2015 4,717 65,398 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters